Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 25935793

Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2015 Jul
First author
Mavroudis D

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2015 Jul;26(7):1275-6. doi: 10.1093/annonc/mdv247.
    note
    Source null
    related pmid
    26002609
    relationship
    Comment in
  2. citation
    Ann Oncol. 2020 Mar;31(3):444-445. doi: 10.1016/j.annonc.2020.01.004.
    note
    Source null
    related pmid
    32067691
    relationship
    Erratum in

Authors and identifiers

  1. name
    Mavroudis D
    type
    Author
  2. name
    Saloustros E
    type
    Author
  3. name
    Malamos N
    type
    Author
  4. name
    Kakolyris S
    type
    Author
  5. name
    Boukovinas I
    type
    Author
  6. name
    Papakotoulas P
    type
    Author
  7. name
    Kentepozidis N
    type
    Author
  8. name
    Ziras N
    type
    Author
  9. name
    Georgoulias V
    type
    Author
  10. name
    Breast Cancer Investigators of Hellenic Oncology Research Group (HORG), Athens, Greece
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Mavroudis D
    type
    Author
  2. name
    Saloustros E
    type
    Author
  3. name
    Malamos N
    type
    Author
  4. name
    Kakolyris S
    type
    Author
  5. name
    Boukovinas I
    type
    Author
  6. name
    Papakotoulas P
    type
    Author
  7. name
    Kentepozidis N
    type
    Author
  8. name
    Ziras N
    type
    Author
  9. name
    Georgoulias V
    type
    Author
  10. name
    Breast Cancer Investigators of Hellenic Oncology Research Group (HORG), Athens, Greece
    type
    CollectiveName
bibliography ids
  1. nci-bib-d88e70d525ce374f524927df
book metadata
content sha256
8bf9135fedd0b34688f92b7bec8005692f78fbfe5c51cb6e908c0ce71e9c8274
document type
citation
dois
  1. 10.1093/annonc/mdv213
electronic publication date
display
2015 May 1
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:25935793
immutable id
pubmed:25935793@8bf9135fedd0b34688f92b7bec8005692f78fbfe5c51cb6e908c0ce71e9c8274
journal
abbreviation
Ann Oncol
issn electronic
1569-8041
issn print
0923-7534
issue
7
name
Annals of oncology : official journal of the European Society for Medical Oncology
nlm unique id
9007735
pages
1333-40
volume
26
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2015 Jul;26(7):1275-6. doi: 10.1093/annonc/mdv247.
    note
    Source null
    related pmid
    26002609
    relationship
    Comment in
  2. citation
    Ann Oncol. 2020 Mar;31(3):444-445. doi: 10.1016/j.annonc.2020.01.004.
    note
    Source null
    related pmid
    32067691
    relationship
    Erratum in
outcomes validated
false
pmid
25935793
provenance
batch id
74265f1b641f04cf2d05
provider
NCBI PubMed ESummary
record sha256
62efc69aca744265ce0f05945e5b760d5d2849535e2806f32d6579424a71de81
response sha256
193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
retrieved at
2026-09-09T23:47:10.134322+00:00
publication date
display
2015 Jul
precision
month
year
2015
publication types
  1. Comparative Study
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25935793/
title
Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG).

Preserved source evidence · Not medical advice